INSPECS Group plc Stock
Stocks
SPEC
GB00BK6JPP03
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
London S.E.
18:35:22 19/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 90.00 GBX | 0.00% |
|
0.00% | +25.87% |
| 09-10 | EARNINGS AND TRADING: Physiomics celebrates new contract wins | AN |
| 09-10 | INSPECS Group plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 131M 117M 108M 98.26M 184M 12.41B 187M 1.3B 510M 6.49B 491M 481M 20.73B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 86.8M 77.37M 71.67M 65.17M 122M 8.23B 124M 860M 338M 4.3B 326M 319M 13.75B | EV / Sales 2026 * |
0.32x | EV / Sales 2027 * | 0.31x |
| Free-Float |
10.75% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SPEC | Delayed | |
Deutsche Boerse AG
| 4GV | Delayed |
| 03-04 | Form 8.3 - Inspecs Group Plc | AQ |
| 02-11 | Form 8.3 - Inspecs Group Plc | AQ |
| 02-09 | Form 8.3 - [INSPECS GROUP PLC - 06 02 2026] - (CGAML) | AQ |
| 01-27 | Form 8.3 - Inspecs Group Plc | AQ |
| 01-07 | Form 8.3 - Inspecs Group Plc | AQ |
| Current month | -3.74% | ||
| 1 month | -6.25% | ||
| 3 months | -7.22% | ||
| 6 months | +7.78% | ||
| Current year | +25.87% |
| 1 week | 87 |  | 90 |
| 1 month | 87 | | 100 |
| Current year | 60 | | 105 |
| 1 year | 40 | | 105 |
| 3 years | 37 | | 105 |
| 5 years | 37 | | 420 |
| 10 years | 37 | | 420 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Peck
CEO | Chief Executive Officer | 62 | 01/12/2022 |
Christopher Kay
DFI | Director of Finance/CFO | 63 | - |
Angela Eman
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Peck
BRD | Director/Board Member | 62 | 10/01/2020 |
Angela Farrugia
BRD | Director/Board Member | 61 | 12/05/2020 |
Luke Johnson
BRD | Director/Board Member | 64 | 19/05/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/4/25 A | Free | Chief Executive Officer | 250,000 | 0.2459% | ||
| 6/4/25 A | Free | Chief Executive Officer | 150,000 | 0.1475% | ||
| 11/8/22 A | Buy | Chief Executive Officer | 833,333 | 0.8196% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +104.55% | +11.11% | 131M | |
| -0.79% | +4.48% | -19.04% | +8.89% | 181B | |
| -2.09% | +4.85% | -3.14% | +27.61% | 116B | |
| +1.11% | +7.43% | -20.43% | +10.27% | 113B | |
| -1.52% | +3.89% | -51.34% | -7.07% | 79.83B | |
| -0.27% | +4.99% | +4.72% | +79.37% | 65.06B | |
| -0.27% | +2.10% | +15.54% | +66.81% | 54.35B | |
| -0.53% | +3.80% | +0.87% | -26.47% | 52.23B | |
| -0.81% | +7.30% | -12.53% | +30.68% | 44.15B | |
| -0.07% | +2.22% | +29.10% | +2.21% | 32.47B | |
| Average | -0.52% | +4.66% | +4.83% | +20.34% | 73.87B | |
| Weighted average by Cap. | -0.65% | +5.50% | -11.68% | +19.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 267M 238M 221M 201M 376M 25.33B 383M 2.65B 1.04B 13.24B 1B 981M 42.32B | 277M 247M 228M 208M 390M 26.23B 396M 2.74B 1.08B 13.71B 1.04B 1.02B 43.83B |
| Net income | - | - |
| Net Debt | -44.08M -39.29M -36.4M -33.09M -62.1M -4.18B -63.12M -437M -172M -2.18B -165M -162M -6.98B | -45.44M -40.5M -37.52M -34.12M -64.02M -4.31B -65.07M -450M -177M -2.25B -170M -167M -7.2B |
Employees
1,656
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/10/26 | GBX 90.00 | 0.00% | 0 |
| 16/10/26 | GBX 90.00 | 0.00% | 0 |
| 15/10/26 | GBX 90.00 | 0.00% | 22 |
| 14/10/26 | GBX 90.00 | 0.00% | 62 |
| 13/10/26 | GBX 90.00 | 0.00% | 0 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.199USD
Average target price
0.8180USD
Spread / Average Target
-31.76%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPEC Stock
Select your edition
All financial news and data tailored to specific country editions
